Market Overview:
The global inhalation and nasal sprays generic drugs market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and rising demand for cost-effective therapies. Based on type, the corticosteroids segment is expected to account for the largest share of the global inhalation and nasal sprays generic drugs market in 2018. This segment is also projected to grow at a highest CAGR during the forecast period. Factors such as increasing incidence of asthma and COPD are driving the growth of this segment.
Product Definition:
Generic drugs are medications that have the same active ingredients as brand-name drugs, but cost less. Generic drugs usually cost 30% to 80% less than the brand-name version.
Corticosteroids:
Corticosteroids are naturally occurring hormones that are produced by the adrenal glands. These steroids are used for the treatment of asthma, bronchitis, rheumatoid arthritis and other autoimmune diseases.
Bronchodilator:
Bronchodilator is a drug that causes dilation of bronchi in the lungs, which helps to improve breathing. Bronchodilators are used for treating chronic obstructive pulmonary disease (COPD), asthma, and other lung diseases. The generic term for bronchodilators is “broncholytic” drugs; these are used to open airways and allow easier breathing.
Application Insights:
The asthma segment dominated the global inhalation and nasal spray generic drugs market in 2017. This is owing to the high prevalence of asthma and other allergic rhinitis disorders. According to estimates reported by Global Asthma Report, around 300 million people are affected by asthma across the globe, which accounts for approximately 1% of total population. In addition, around 15 million people suffer from severe asthma and about 500 thousand die due to this condition every year globally.
Accordingly, sales of anti-asthma inhalers/pumps were highest in 2017 while that for bronchodilators was moderate in nature during same period last year due to fewer launches compared with 2017 as well as fewer approvals from regulatory bodies such as U.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high disease prevalence and awareness regarding available generic drugs are some of the factors responsible for its large share. Furthermore, increasing R&D investment by companies to develop inhalation and nasal sprays is expected to contribute towards its growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rising disposable income coupled with improving healthcare facilities in emerging countries such as China and India. Moreover, government initiatives encouraging generic drug manufacturing are also likely boost regional growth during future years.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for inhalation and nasal sprays generic drugs in the coming years.
- Growing awareness about benefits of generic drugs: There is a growing awareness among consumers about the benefits of using generic drugs, which is expected to boost the demand for inhalation and nasal sprays generic drugs in the near future.
- Rising number of product launches: The number of product launches in this market is rising as manufacturers are launching new products to cater to the growing demand from consumers. This will help fuel growth in this market during the forecast period.
- Technological advancements: The technological advancements taking place in this market are helping manufacturers develop better products that offer better results than traditional therapies do, thereby fuelling growth prospects for this market during the forecast period . 5) Increasing patient preference for self-medication: Patients are preferring self-medication over visiting a doctor or hospital, which is driving growth prospects for inhalation and nasal sprays generics drug market duringthe forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Inhalation and Nasal Sprays Generic Drugs Market Research Report
By Type
Corticosteroids, Bronchodilator, Antihistamine, Congestive Spray, Other
By Application
Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Other
By Companies
Allergan, Beximco Pharmaceuticals Ltd, Cipla Limited, Mylan N.V., Nephron Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Novartis, Perrigo Company, Catalent Pharma Solutions, Teva Pharmaceutical Industries Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Inhalation and Nasal Sprays Generic Drugs Market Report Segments:
The global Inhalation and Nasal Sprays Generic Drugs market is segmented on the basis of:
Types
Corticosteroids, Bronchodilator, Antihistamine, Congestive Spray, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Beximco Pharmaceuticals Ltd
- Cipla Limited
- Mylan N.V.
- Nephron Pharmaceuticals Corporation
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Novartis
- Perrigo Company
- Catalent Pharma Solutions
- Teva Pharmaceutical Industries Ltd.
Highlights of The Inhalation and Nasal Sprays Generic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Bronchodilator
- Antihistamine
- Congestive Spray
- Other
- By Application:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Allergic Rhinitis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhalation and Nasal Sprays Generic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inhalation and nasal sprays are generic drugs because they are made to imitate the name brand medications.
Some of the major players in the inhalation and nasal sprays generic drugs market are Allergan, Beximco Pharmaceuticals Ltd, Cipla Limited, Mylan N.V., Nephron Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Novartis, Perrigo Company, Catalent Pharma Solutions, Teva Pharmaceutical Industries Ltd..
The inhalation and nasal sprays generic drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inhalation and Nasal Sprays Generic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inhalation and Nasal Sprays Generic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inhalation and Nasal Sprays Generic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inhalation and Nasal Sprays Generic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inhalation and Nasal Sprays Generic Drugs Market Size & Forecast, 2018-2028
4.5.1 Inhalation and Nasal Sprays Generic Drugs Market Size and Y-o-Y Growth
4.5.2 Inhalation and Nasal Sprays Generic Drugs Market Absolute $ Opportunity
Chapter 5 Global Inhalation and Nasal Sprays Generic Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
5.2.1 Corticosteroids
5.2.2 Bronchodilator
5.2.3 Antihistamine
5.2.4 Congestive Spray
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Inhalation and Nasal Sprays Generic Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
6.2.1 Asthma
6.2.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.3 Allergic Rhinitis
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inhalation and Nasal Sprays Generic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Inhalation and Nasal Sprays Generic Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
9.6.1 Corticosteroids
9.6.2 Bronchodilator
9.6.3 Antihistamine
9.6.4 Congestive Spray
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
9.10.1 Asthma
9.10.2 Chronic Obstructive Pulmonary Disease (COPD)
9.10.3 Allergic Rhinitis
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Inhalation and Nasal Sprays Generic Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
10.6.1 Corticosteroids
10.6.2 Bronchodilator
10.6.3 Antihistamine
10.6.4 Congestive Spray
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
10.10.1 Asthma
10.10.2 Chronic Obstructive Pulmonary Disease (COPD)
10.10.3 Allergic Rhinitis
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Inhalation and Nasal Sprays Generic Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
11.6.1 Corticosteroids
11.6.2 Bronchodilator
11.6.3 Antihistamine
11.6.4 Congestive Spray
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
11.10.1 Asthma
11.10.2 Chronic Obstructive Pulmonary Disease (COPD)
11.10.3 Allergic Rhinitis
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Inhalation and Nasal Sprays Generic Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
12.6.1 Corticosteroids
12.6.2 Bronchodilator
12.6.3 Antihistamine
12.6.4 Congestive Spray
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
12.10.1 Asthma
12.10.2 Chronic Obstructive Pulmonary Disease (COPD)
12.10.3 Allergic Rhinitis
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Inhalation and Nasal Sprays Generic Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Type
13.6.1 Corticosteroids
13.6.2 Bronchodilator
13.6.3 Antihistamine
13.6.4 Congestive Spray
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Inhalation and Nasal Sprays Generic Drugs Market Size Forecast by Applications
13.10.1 Asthma
13.10.2 Chronic Obstructive Pulmonary Disease (COPD)
13.10.3 Allergic Rhinitis
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inhalation and Nasal Sprays Generic Drugs Market: Competitive Dashboard
14.2 Global Inhalation and Nasal Sprays Generic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Beximco Pharmaceuticals Ltd
14.3.3 Cipla Limited
14.3.4 Mylan N.V.
14.3.5 Nephron Pharmaceuticals Corporation
14.3.6 Sun Pharmaceutical Industries Ltd.
14.3.7 Hikma Pharmaceuticals
14.3.8 Novartis
14.3.9 Perrigo Company
14.3.10 Catalent Pharma Solutions
14.3.11 Teva Pharmaceutical Industries Ltd.
